Stay updated on Psilocybin-Induced Neuroplasticity in MDD Clinical Trial
Sign up to get notified when there's something new on the Psilocybin-Induced Neuroplasticity in MDD Clinical Trial page.

Latest updates to the Psilocybin-Induced Neuroplasticity in MDD Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check21 days agoChange DetectedThe webpage has updated its version from v2.16.10 to v2.16.11 and has added new dates for August and September 2025 while removing previous dates from May and June 2025.SummaryDifference1%
- Check29 days agoChange DetectedThe web page has added a new clinical study on psilocybin's effects on major depressive disorder, sponsored by Yale University, which includes detailed information about the study's design, eligibility criteria, and outcome measures. Additionally, the page now includes a disclaimer about the U.S. government's non-review of all studies listed.SummaryDifference100%
- Check36 days agoChange DetectedThe webpage has removed significant content related to a clinical study on psilocybin and major depressive disorder, including details about the study's design, eligibility criteria, and outcomes. Additionally, the page now includes a new error message regarding server issues.SummaryDifference100%
- Check43 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.1%
- Check50 days agoChange DetectedA service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference1%
Stay in the know with updates to Psilocybin-Induced Neuroplasticity in MDD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin-Induced Neuroplasticity in MDD Clinical Trial page.